Prolacta logo_singlecolor.png
Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study
08 sept. 2020 09h05 HE | Prolacta Bioscience
DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a new...
Length-of-Stay-Social-Media-Graphics-1080-x-1080-post-1-v02
Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most
30 juil. 2020 09h05 HE | Prolacta Bioscience
DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...
Prolacta logo_singlecolor.png
Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers
14 juil. 2020 09h05 HE | Prolacta Bioscience
DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...
Prolacta logo_singlecolor.png
Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
01 juin 2020 09h05 HE | Prolacta Bioscience
DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...
Prolacta logo_singlecolor.png
Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers
12 mai 2020 09h05 HE | Prolacta Bioscience
DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...
Prolacta logo_singlecolor.png
UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
02 avr. 2020 23h55 HE | Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta logo_singlecolor.png
Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
02 avr. 2020 15h50 HE | Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta logo_singlecolor.png
Prolacta Bioscience Congratulates Terry Johnson for Lifetime Achievement Award in Neonatal Nursing
21 nov. 2019 09h05 HE | Prolacta Bioscience
DUARTE, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, is proud to announce that one of its...
Prolacta logo_singlecolor.png
Despite Worsening Prematurity Birth Rate, Odds of Survival Improving with NICU Adoption of Prolacta’s 100% Human Milk-Based Fortifiers
19 nov. 2019 09h05 HE | Prolacta Bioscience
DUARTE, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, is helping neonatal intensive care units...
Prolacta logo_singlecolor.png
Study Reveals an Exclusive Human Milk Diet With Prolact+ H2MF, Prolacta’s 100% Breastmilk-Based Fortifier, Substantially Reduces Costs Due to Complications in the NICU
12 nov. 2019 09h05 HE | Prolacta Bioscience
DUARTE, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- New research demonstrates that an exclusive human milk diet (EHMD)1, including a 100% donor breastmilk-based fortifier, Prolact+ H2MF, manufactured...